TGF-B signaling pathway molecular regulation by smads in myelofibrosis patients (2014)
- Authors:
- Nunes, Daniela Prudente teixeira
- Lima, Luciene Terezinha de
- Gomes, Guilherme Wataru
- Yassui, Celina Garcia
- Chauffaille, Maria de Lourdes
- Silva, M. R. R - Universidade Federal de São Paulo (UNIFESP)
- Ponce, C. C - Universidade Federal de São Paulo (UNIFESP)
- Castro, Fabíola Attié de
- Guerra-Shinohara, Elvira Maria
- USP affiliated authors: CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; SHINOHARA, ELVIRA MARIA GUERRA - FCF
- Unidades: FCFRP; FCF
- Subjects: HEMATOLOGIA; LEUCEMIA MIELOIDE
- Language: Inglês
- Imprenta:
- Source:
- Título: Haematologica
- ISSN: 0390-6078
- Volume/Número/Paginação/Ano: v. 99, suppl. 1, p. 660-661 res. PB1714, 2014
- Conference titles: Congress of the European Hematology Association
-
ABNT
NUNES, Daniela Prudente teixeira et al. TGF-B signaling pathway molecular regulation by smads in myelofibrosis patients. Haematologica. Pavia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 14 mar. 2026. , 2014 -
APA
Nunes, D. P. teixeira, Lima, L. T. de, Gomes, G. W., Yassui, C. G., Chauffaille, M. de L., Silva, M. R. R., et al. (2014). TGF-B signaling pathway molecular regulation by smads in myelofibrosis patients. Haematologica. Pavia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. -
NLM
Nunes DP teixeira, Lima LT de, Gomes GW, Yassui CG, Chauffaille M de L, Silva MRR, Ponce CC, Castro FA de, Guerra-Shinohara EM. TGF-B signaling pathway molecular regulation by smads in myelofibrosis patients. Haematologica. 2014 ; 99 660-661 res. PB1714.[citado 2026 mar. 14 ] -
Vancouver
Nunes DP teixeira, Lima LT de, Gomes GW, Yassui CG, Chauffaille M de L, Silva MRR, Ponce CC, Castro FA de, Guerra-Shinohara EM. TGF-B signaling pathway molecular regulation by smads in myelofibrosis patients. Haematologica. 2014 ; 99 660-661 res. PB1714.[citado 2026 mar. 14 ] - Gene expression and protein levels of MMPS, TIMPS and SPARC and their relationship with plasma markers of angiogenesis in myelofibrosis and essential thrombocythemia patients
- JAK-STAT pathway inhibitor do not modulate drug transporters gene expressions in JAK2V617F positive cell line
- Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia
- Pharmacological interference with the apoptosis machinery
- Overexpression of the anti-apoptotic genes mcl-1, bcl-W, bcl-XL and a1 correlates with CML progression and resistance to Gleevec
- Estímulo da expressão dos antígenos HLA-DR em leucemias
- Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias
- A1, survivin and c-FLIP anti-apoptotic genes overexpression in head and neck squamous cell carcinoma (HNSCC) patients
- Genomic approach to undertand the mechenisms involved in BCR-ABL mediated resistance to apoptosis
- Alterações imunológicas associadas ao uso de interferon-'alfa' na leucemia mielóide
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
